Viking Therapeutics, Inc. (VKTX) NASDAQ
35.63
+0.16(+0.45%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
35.63
+0.16(+0.45%)
Currency In USD
| Market Cap | 3.96B |
| Enterprise Value | 3.8B |
| P/E Ratio | -11.29 |
| PEG Ratio | 0.23 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.36 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.5 |
| Return On Equity | -0.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -431,000 |
| EBITDA | -393.34M |
| Net Income | -359.64M |
| Diluted EPS | -3.19 |
| Total Cash | 705.74M |
| Total Cash/Share | 6.19 |
| Total Debt | 137,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 9.33 |
| Book Value Per Share | 5.61 |
| 52-Week Change | 15.34 |
| 52-Week High | 43.15 |
| 52-Week Low | 18.92 |
| Moving Average 50 Days | 31.94 |
| Moving Average 200 Days | 31.77 |
| Average Volume | 2.96M |
| Shares Outstanding | 115.55M |
| % Held by Institutions | 64.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |